Moreover, huFLT3L treatment was associated with significantly increased proliferation (Ki-67+ staining) of OVA-specific CD4 and CD8 T cells in tumor-draining lymph nodes (figure 4D) and spleen (online supplemental figure S4E). Here, CD4 is linked to neoplasm.